CVE-2022-33955

CVE-2022-33955 is a medium-severity vulnerability in Ibm Cics Tx with a CVSS 3.x base score of 6.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-78.

Key facts

Description

IBM CICS TX 11.1 could allow allow an attacker with physical access to the system to execute code due using a back and refresh attack. IBM X-Force ID: 229312.

Frequently asked questions

What is CVE-2022-33955?
IBM CICS TX 11.1 could allow allow an attacker with physical access to the system to execute code due using a back and refresh attack. IBM X-Force ID: 229312.
How severe is CVE-2022-33955?
CVE-2022-33955 has a CVSS 3.x base score of 6.8, rated medium severity. It is exploitable over physical access with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
Is CVE-2022-33955 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (41st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2022-33955?
CVE-2022-33955 primarily affects Ibm Cics Tx. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2022-33955?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2022-33955 published?
CVE-2022-33955 was published on 2022-08-01 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Ibm Cics Tx

All CVEs affecting Ibm Cics Tx →

Other CWE-78 (OS Command Injection) vulnerabilities

Browse all CWE-78 (OS Command Injection) vulnerabilities →